Track Neurobiological Technologies's receivables ($3M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Neurobiological Technologies (NTII) currently reports a receivables of $3M as of September 2009. That compares with $180K in the prior-year period — up 1530.4% year over year. Use the charts on this page to explore Neurobiological Technologies's receivables history and peer comparisons.
Neurobiological Technologies's receivables increased from $180K to $3M — a 1530.4% year-over-year increase (period ending September 2009). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Neurobiological Technologies reported $3M in receivables as of September 2009. That compares with $180K in the prior-year period — up 1530.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neurobiological Technologies, and consider following NTII for alerts when major investors trade the stock.
Neurobiological Technologies is classified in the Healthcare sector. On receivables, it currently shows $3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NTII with unrelated industries.